Bharat Parenterals Ltd
BSE:541096
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bharat Parenterals Ltd
Accounts Payable
Bharat Parenterals Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bharat Parenterals Ltd
BSE:541096
|
Accounts Payable
₹576.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Accounts Payable
₹35.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Accounts Payable
₹30.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Accounts Payable
₹67.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Accounts Payable
₹34.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Accounts Payable
₹16.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
Bharat Parenterals Ltd
Glance View
Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2018-03-21. The firm is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The firm offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other.
See Also
What is Bharat Parenterals Ltd's Accounts Payable?
Accounts Payable
576.8m
INR
Based on the financial report for Dec 31, 2025, Bharat Parenterals Ltd's Accounts Payable amounts to 576.8m INR.
What is Bharat Parenterals Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
7%
Over the last year, the Accounts Payable growth was 32%. The average annual Accounts Payable growth rates for Bharat Parenterals Ltd have been 10% over the past three years , 7% over the past five years .
